105 related articles for article (PubMed ID: 18190237)
1. Gp96 and its different expression in breast carcinomas.
Hodorova I; Rybarova S; Solar P; Vecanova J; Prokopcakova L; Bohus P; Solarova Z; Mellova Y; Schmidtova K
Neoplasma; 2008; 55(1):31-5. PubMed ID: 18190237
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical versus molecular detection of RAK antigens in breast cancer.
Kyriacou KC; Iacovou F; Adamou A; Hadjisavvas A; Rakowicz-Szulczynska EM
Exp Mol Pathol; 2000 Aug; 69(1):27-36. PubMed ID: 10891290
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
Wahed A; Connelly J; Reese T
Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
[TBL] [Abstract][Full Text] [Related]
4. CD109 expression in basal-like breast carcinoma.
Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
[TBL] [Abstract][Full Text] [Related]
6. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
Goldstein NS
Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
[TBL] [Abstract][Full Text] [Related]
7. Expression of periostin in human breast cancer.
Puglisi F; Puppin C; Pegolo E; Andreetta C; Pascoletti G; D'Aurizio F; Pandolfi M; Fasola G; Piga A; Damante G; Di Loreto C
J Clin Pathol; 2008 Apr; 61(4):494-8. PubMed ID: 17938160
[TBL] [Abstract][Full Text] [Related]
8. The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells.
Assmann V; Gillett CE; Poulsom R; Ryder K; Hart IR; Hanby AM
J Pathol; 2001 Sep; 195(2):191-6. PubMed ID: 11592098
[TBL] [Abstract][Full Text] [Related]
9. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis.
Isidoro A; Casado E; Redondo A; Acebo P; Espinosa E; Alonso AM; Cejas P; Hardisson D; Fresno Vara JA; Belda-Iniesta C; González-Barón M; Cuezva JM
Carcinogenesis; 2005 Dec; 26(12):2095-104. PubMed ID: 16033770
[TBL] [Abstract][Full Text] [Related]
10. The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges.
Wang-Rodriguez J; Dreilinger AD; Alsharabi GM; Rearden A
Cancer; 2002 Sep; 95(6):1387-95. PubMed ID: 12216108
[TBL] [Abstract][Full Text] [Related]
11. Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.
Laser J; Cangiarella J; Singh B; Melamed J; Chiriboga L; Yee H; Darvishian F
Ann Clin Lab Sci; 2008; 38(2):99-104. PubMed ID: 18469353
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma.
Jaffer S; Orta L; Sunkara S; Sabo E; Burstein DE
Hum Pathol; 2007 Jun; 38(6):864-70. PubMed ID: 17350670
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of galectin-3 is associated with progression of human breast cancer.
Castronovo V; Van Den Brûle FA; Jackers P; Clausse N; Liu FT; Gillet C; Sobel ME
J Pathol; 1996 May; 179(1):43-8. PubMed ID: 8691344
[TBL] [Abstract][Full Text] [Related]
15. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
16. BigH3 protein expression as a marker for breast cancer.
Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
[TBL] [Abstract][Full Text] [Related]
18. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
19. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
Chipysheva TA; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM
Arkh Patol; 2005; 67(6):24-7. PubMed ID: 16405017
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical visualisation of cathepsin-D expression in breast cancer.
Barthell E; Mylonas I; Shabani N; Kunze S; Kuhn C; Jeschke U; Friese K
Anticancer Res; 2007; 27(4A):2035-9. PubMed ID: 17649818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]